novel
coronaviru
threat
health
wellb
million
life
across
globe
signific
proport
adult
patient
requir
hospitalis
may
develop
sever
lifethreaten
complic
children
hand
carri
transmit
viru
usual
develop
sever
diseas
mortal
paediatr
agegroup
rel
low
differ
viru
contain
clearanc
well
reduc
inflammationrel
tissu
organ
damag
may
caus
agespecif
environment
host
factor
sinc
sever
complic
adult
frequent
caus
uncontrol
immun
respons
result
cytokin
storm
may
control
target
blockad
cytokin
previous
establish
treatment
immunosuppress
treatment
may
inde
protect
children
complic
pathogen
caus
pandem
threaten
million
life
global
individu
infect
unappar
associ
mild
moder
symptom
mani
develop
sever
lifethreaten
diseas
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
surprisingli
airborn
viral
infect
number
children
diagnos
rel
small
confirm
case
china
children
young
peopl
year
diseaseassoci
mortal
among
children
low
tabl
molecular
studi
target
pathophysiolog
spars
clinic
molecular
parallel
relat
coronavirus
sar
merscov
may
extrapol
infect
immun
evas
sarscov
use
entri
receptor
facilit
infect
reflect
common
organ
involv
express
pulmonari
intestin
epitheli
cell
express
small
subset
immun
cell
receptor
andor
phagocytosi
viruscontain
immun
complex
may
involv
infect
sarscov
share
potenti
escap
host
immun
respons
usual
rna
virus
includ
coronavirus
detect
endosom
andor
cytoplasm
rna
sensor
rigi
promot
nuclear
shuttl
transcript
factor
ligat
result
activ
trigger
increas
express
type
interferon
innat
proinflammatori
cytokin
induc
antivir
state
innat
adapt
immun
cell
respons
contribut
pathogen
contain
clearanc
novel
coronavirus
escap
mechan
alter
ubiquitin
degrad
adaptor
molecul
mitochondri
antiviralsignal
protein
mav
inhibit
nuclear
transloc
tnf
receptorassoci
factor
traf
induc
signal
furthermor
sarscov
counteract
inhibit
stat
transcript
factor
phosphoryl
associ
poor
outcom
earli
studi
china
link
cytopenia
leukopenia
lymphopenia
anaemia
thrombcytopenia
elev
inflammatori
paramet
crp
esr
unfavour
outcom
suggest
cytokin
storm
syndrom
patient
icu
depend
particular
associ
increas
plasma
level
innat
chemokin
proinflammatori
cytokin
though
seemingli
contradictori
aforement
immun
evas
reduc
cytokin
express
enhanc
innat
immun
activ
promot
morbid
mortal
howev
possibl
contributor
uncontrol
inflamm
cell
damag
death
result
viral
replic
sarscov
infect
mice
innat
immun
cell
recruit
site
infect
induc
strong
inflammatori
respons
promot
tissu
damag
system
inflamm
anoth
mechan
contribut
poor
outcom
may
antibodydepend
enhanc
caus
earli
antibodi
product
result
viruscontain
immun
complex
promot
cellular
uptak
viru
particl
receptor
may
result
persist
viral
replic
cell
includ
antigenpres
cell
immun
complex
mediat
inflamm
damag
inde
blood
vessel
occlus
j
u
r
n
l
p
r
e
p
r
f
infarct
report
covid
show
histopatholog
featur
associ
immun
complex
vascul
children
get
sicker
current
known
children
usual
develop
mildmoder
diseas
rare
develop
cytokin
storm
syndrom
tabl
sever
contributor
may
alter
risk
children
children
travel
busi
reduc
exposur
peopl
may
play
role
begin
pandem
ii
pathogen
clearanc
may
reduc
adult
particularli
individu
risk
elderli
patient
diabet
etc
children
fewer
comorbid
includ
obes
iii
differ
immun
respons
compar
adult
includ
strong
innat
weaker
adapt
immun
respons
may
contribut
effect
viru
containmentclear
andor
reduc
secondari
lymphocytemedi
inflamm
iv
local
microbiom
coinfect
coclear
virus
andor
immun
prime
coronaviru
infect
result
frequentconst
exposur
may
help
children
overcom
effect
v
essenti
epitheli
cell
infect
also
control
pulmonari
inflamm
repair
variabl
express
pattern
may
affect
diseas
suscept
progress
evidencebas
approv
treatment
andor
associ
cytokin
storm
syndrom
though
children
receiv
immunosuppress
treatment
may
increas
risk
infect
immunosuppress
may
protect
complic
antimalari
treatment
chloroquinehydroxychloroquin
may
prevent
infect
endocytosi
classic
andor
biolog
dmard
particularli
blocker
may
control
proinflammatori
cytokin
express
limit
tissueorgan
damag
delay
activ
adapt
immun
respons
may
benefit
earli
antibodi
product
may
promot
infect
immun
cell
andor
caus
immun
complex
mediat
patholog
intern
collabor
need
safe
assess
individu
risk
vulner
patient
group
reliabl
data
avail
close
clinic
monitor
social
distanc
priorit
collect
prospect
data
requir
improv
evid
base
current
avail
dataset
chines
cohort
children
experienc
mild
moder
diseas
children
summaris
tabl
sever
critic
ill
bold
ital
die
children
develop
sever
consist
exhibit
clinic
andor
laboratori
sign
cytokin
storm
syndrom
cytopenia
al
tere
liver
function
data
limit
appear
contrast
adult
cohort
signific
proport
sever
ill
patient
show
sign
cytokin
storm
syndrom
associ
poor
outcom
abbrevi
wbc
white
blood
count
hb
haemoglobin
plt
platelet
count
crp
c
reactiv
protein
esr
erythrocyt
sediment
rate
lft
liver
function
test
ast
andor
alt
elev
na
avail
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
